Loading data for HAE — first visit, this takes a few seconds.

Alerta

Haemonetics Corporation (HAE)

NYSE: HAE · Precio en tiempo real · USD

108.80

+0.58 (0.54%)

Al cierre: Aug 21, 2026, 8:00 PM

108.80

+0.00%

Fuera de horario: 7:30 PM

El precio, las cifras principales y las últimas noticias, en un solo sitio.

0.54% (1D)

No hay datos disponibles

Precio de compra	107.88
Capitalización de mercado	4.95B
Ingresos (TTM)	1.35B
Beneficio neto (TTM)	96.29M
	0.52
	2.07
	52.56
	18.96
P/B (TTM)	5.91
P/S (TTM)	3.66
Fecha de resultados	Nov 5, 2026

Precio de venta	115.5
Volumen	443,490
Volumen medio (20D)	885,020
Abierto	109.24
Anterior Cerrar	108.22
Rango del día	107.01 - 109.57
Rango de 52 semanas	47.32 - 109.57
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de HAE

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma c...

[Leer más]

Industria Medical Devices

Sector Healthcare

IPO Fecha May 10, 1991

Empleados 3,009

Bolsa de Valores NYSE

Símbolo bursátil HAE

Sitio web https://www.haemonetics.com

Perfil completo de la empresa

Desempeño financiero

En 2026, los ingresos de Haemonetics fueron 1.33B, una disminución de -1.97% en comparación con 1.36B del año anterior. Las ganancias fueron 97.31M, una disminución de -41.97%.

Estados financieros

Sorpresa de resultados

Haemonetics ha publicado sus resultados trimestrales en Aug 6, 2026:

Ingresos de $339.38M falla las estimaciones por $0, con 5.60% Crecimiento interanual.
EPS de 1.14 supera las estimaciones en 0.06, con 3.64% Crecimiento interanual.

Próxima publicación de resultados

Está previsto que Haemonetics Corporation publique sus resultados el Nov 5, 2026, antes de que se abra el mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

1 día hace · StockStory

Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Haemonetics (NYSE:HAE) and its peers.

2 días hace · StockStory

1 Russell 2000 Stock with Competitive Advantages and 2 We Turn Down

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these ...

4 días hace · MT Newswires

Sector Update: Healthcare Stocks Climb Late Afternoon

Healthcare stocks were higher late Tuesday afternoon, with the NYSE Healthcare Index and the State S

5 días hace · StockStory

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other busine...

6 días hace · Simply Wall St.

Haemonetics (HAE) Stock Could Be 49% Below Fair Value On Raised Guidance

Haemonetics stock has delivered a strong 69.0% return over the past year, yet the valuation signals are mixed, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model suggesting t...

Página 1 de 2

Haemonetics Corporation (HAE)